Chronic kidney disease
Ardelyx wins FDA approval for Xphozah, a new drug for chronic kidney disease
Ardelyx’s perseverance pays off as the FDA grants approval for its groundbreaking medication, Xphozah (tenapanor), marking the third attempt as ...
Novo Nordisk acquires Corvidia Therapeutics for $1.3B to compete with Bayer’s Kerendia
Novo Nordisk, riding high on the success of its semaglutide sales, has taken a strategic leap by investing up to ...
Novo’s Ozempic shows promise in kidney disease, but DaVita questions its real-world benefits
Novo Nordisk’s GLP-1 blockbuster Ozempic appears to be making significant strides in the treatment of chronic kidney disease (CKD), potentially ...
Semaglutide’s Remarkable Success in Kidney Disease Trial Prompts Early Completion
In a recent development surrounding the study of injectable semaglutide’s efficacy in chronic kidney disease, Novo Nordisk has found reason ...
AstraZeneca Settles Nexium, Prilosec Lawsuits for $425M
AstraZeneca has agreed to pay £352 million ($425 million) to settle approximately 11,000 personal injury lawsuits in New Jersey and ...
Jardiance gets FDA green light for chronic kidney disease, challenging AstraZeneca’s rival drug
Shortly after securing European approval for the treatment of chronic kidney disease (CKD), Eli Lilly and Boehringer Ingelheim have achieved ...
Boehringer Ingelheim Soars with Jardiance Growth as US Kidney Disease Approval Looms
Source – Boehringer Ingelheim Boehringer Ingelheim is gearing up for the launch of Jardiance, a diabetes and heart failure drug, ...
Jardiance Receives EU Approval for Treating Chronic Kidney Disease (CKD), Posing a Strong Challenge to Forxiga
Source – Boehringer Ingelheim The European Union has granted approval for Boehringer Ingelheim and Eli Lilly’s SGLT2 inhibitor, Jardiance (empagliflozin), ...
Bayer Initiates Phase III Trial of Finerenone in Adults with Type 1 Diabetes and Chronic Kidney Disease
Source – Bayer On June 22, 2023, Bayer Initiates Phase III Trial of Finerenone, Bayer announced the initiation of a ...
